Global Aurora Kinase A Market Growth 2025-2031
The global Aurora Kinase A market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
United States market for Aurora Kinase A is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Aurora Kinase A is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Aurora Kinase A is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Aurora Kinase A players cover AbbVie Inc., Amgen Inc., Astex Pharmaceuticals, Inc., CASI Pharmaceuticals Inc., Merck & Co., Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the ?Aurora Kinase A Industry Forecast? looks at past sales and reviews total world Aurora Kinase A sales in 2024, providing a comprehensive analysis by region and market sector of projected Aurora Kinase A sales for 2025 through 2031. With Aurora Kinase A sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aurora Kinase A industry.
This Insight Report provides a comprehensive analysis of the global Aurora Kinase A landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aurora Kinase A portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Aurora Kinase A market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aurora Kinase A and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aurora Kinase A.
This report presents a comprehensive overview, market shares, and growth opportunities of Aurora Kinase A market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Aurora Kinase A market?
What factors are driving Aurora Kinase A market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aurora Kinase A market opportunities vary by end market size?
How does Aurora Kinase A break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
United States market for Aurora Kinase A is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Aurora Kinase A is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Aurora Kinase A is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Aurora Kinase A players cover AbbVie Inc., Amgen Inc., Astex Pharmaceuticals, Inc., CASI Pharmaceuticals Inc., Merck & Co., Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the ?Aurora Kinase A Industry Forecast? looks at past sales and reviews total world Aurora Kinase A sales in 2024, providing a comprehensive analysis by region and market sector of projected Aurora Kinase A sales for 2025 through 2031. With Aurora Kinase A sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aurora Kinase A industry.
This Insight Report provides a comprehensive analysis of the global Aurora Kinase A landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aurora Kinase A portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Aurora Kinase A market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aurora Kinase A and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aurora Kinase A.
This report presents a comprehensive overview, market shares, and growth opportunities of Aurora Kinase A market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- AMG-900
- Danusertib
- ENMD-2076
- Ilorasertib
- Others
- Ovarian Cancer
- Anaplastic Large Cell Lymphoma
- Brain Tumor
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie Inc.
- Amgen Inc.
- Astex Pharmaceuticals, Inc.
- CASI Pharmaceuticals Inc.
- Merck & Co., Inc.
- Millennium Pharmaceuticals, Inc.
- Sanofi
- Sareum Holdings Plc
- Sigma-Tau S.p.A.
- Taiho Pharmaceutical Co., Ltd.
- Vertex Pharmaceuticals Incorporated
- Vichem Chemie Research Ltd.
What is the 10-year outlook for the global Aurora Kinase A market?
What factors are driving Aurora Kinase A market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aurora Kinase A market opportunities vary by end market size?
How does Aurora Kinase A break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Aurora Kinase A Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Aurora Kinase A by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Aurora Kinase A by Country/Region, 2020, 2024 & 2031
2.2 Aurora Kinase A Segment by Type
2.2.1 AMG-900
2.2.2 Danusertib
2.2.3 ENMD-2076
2.2.4 Ilorasertib
2.2.5 Others
2.3 Aurora Kinase A Sales by Type
2.3.1 Global Aurora Kinase A Sales Market Share by Type (2020-2025)
2.3.2 Global Aurora Kinase A Revenue and Market Share by Type (2020-2025)
2.3.3 Global Aurora Kinase A Sale Price by Type (2020-2025)
2.4 Aurora Kinase A Segment by Application
2.4.1 Ovarian Cancer
2.4.2 Anaplastic Large Cell Lymphoma
2.4.3 Brain Tumor
2.4.4 Others
2.5 Aurora Kinase A Sales by Application
2.5.1 Global Aurora Kinase A Sale Market Share by Application (2020-2025)
2.5.2 Global Aurora Kinase A Revenue and Market Share by Application (2020-2025)
2.5.3 Global Aurora Kinase A Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Aurora Kinase A Breakdown Data by Company
3.1.1 Global Aurora Kinase A Annual Sales by Company (2020-2025)
3.1.2 Global Aurora Kinase A Sales Market Share by Company (2020-2025)
3.2 Global Aurora Kinase A Annual Revenue by Company (2020-2025)
3.2.1 Global Aurora Kinase A Revenue by Company (2020-2025)
3.2.2 Global Aurora Kinase A Revenue Market Share by Company (2020-2025)
3.3 Global Aurora Kinase A Sale Price by Company
3.4 Key Manufacturers Aurora Kinase A Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aurora Kinase A Product Location Distribution
3.4.2 Players Aurora Kinase A Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AURORA KINASE A BY GEOGRAPHIC REGION
4.1 World Historic Aurora Kinase A Market Size by Geographic Region (2020-2025)
4.1.1 Global Aurora Kinase A Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Aurora Kinase A Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Aurora Kinase A Market Size by Country/Region (2020-2025)
4.2.1 Global Aurora Kinase A Annual Sales by Country/Region (2020-2025)
4.2.2 Global Aurora Kinase A Annual Revenue by Country/Region (2020-2025)
4.3 Americas Aurora Kinase A Sales Growth
4.4 APAC Aurora Kinase A Sales Growth
4.5 Europe Aurora Kinase A Sales Growth
4.6 Middle East & Africa Aurora Kinase A Sales Growth
5 AMERICAS
5.1 Americas Aurora Kinase A Sales by Country
5.1.1 Americas Aurora Kinase A Sales by Country (2020-2025)
5.1.2 Americas Aurora Kinase A Revenue by Country (2020-2025)
5.2 Americas Aurora Kinase A Sales by Type (2020-2025)
5.3 Americas Aurora Kinase A Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aurora Kinase A Sales by Region
6.1.1 APAC Aurora Kinase A Sales by Region (2020-2025)
6.1.2 APAC Aurora Kinase A Revenue by Region (2020-2025)
6.2 APAC Aurora Kinase A Sales by Type (2020-2025)
6.3 APAC Aurora Kinase A Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Aurora Kinase A by Country
7.1.1 Europe Aurora Kinase A Sales by Country (2020-2025)
7.1.2 Europe Aurora Kinase A Revenue by Country (2020-2025)
7.2 Europe Aurora Kinase A Sales by Type (2020-2025)
7.3 Europe Aurora Kinase A Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Aurora Kinase A by Country
8.1.1 Middle East & Africa Aurora Kinase A Sales by Country (2020-2025)
8.1.2 Middle East & Africa Aurora Kinase A Revenue by Country (2020-2025)
8.2 Middle East & Africa Aurora Kinase A Sales by Type (2020-2025)
8.3 Middle East & Africa Aurora Kinase A Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aurora Kinase A
10.3 Manufacturing Process Analysis of Aurora Kinase A
10.4 Industry Chain Structure of Aurora Kinase A
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aurora Kinase A Distributors
11.3 Aurora Kinase A Customer
12 WORLD FORECAST REVIEW FOR AURORA KINASE A BY GEOGRAPHIC REGION
12.1 Global Aurora Kinase A Market Size Forecast by Region
12.1.1 Global Aurora Kinase A Forecast by Region (2026-2031)
12.1.2 Global Aurora Kinase A Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Aurora Kinase A Forecast by Type (2026-2031)
12.7 Global Aurora Kinase A Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AbbVie Inc.
13.1.1 AbbVie Inc. Company Information
13.1.2 AbbVie Inc. Aurora Kinase A Product Portfolios and Specifications
13.1.3 AbbVie Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AbbVie Inc. Main Business Overview
13.1.5 AbbVie Inc. Latest Developments
13.2 Amgen Inc.
13.2.1 Amgen Inc. Company Information
13.2.2 Amgen Inc. Aurora Kinase A Product Portfolios and Specifications
13.2.3 Amgen Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Amgen Inc. Main Business Overview
13.2.5 Amgen Inc. Latest Developments
13.3 Astex Pharmaceuticals, Inc.
13.3.1 Astex Pharmaceuticals, Inc. Company Information
13.3.2 Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolios and Specifications
13.3.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Astex Pharmaceuticals, Inc. Main Business Overview
13.3.5 Astex Pharmaceuticals, Inc. Latest Developments
13.4 CASI Pharmaceuticals Inc.
13.4.1 CASI Pharmaceuticals Inc. Company Information
13.4.2 CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolios and Specifications
13.4.3 CASI Pharmaceuticals Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 CASI Pharmaceuticals Inc. Main Business Overview
13.4.5 CASI Pharmaceuticals Inc. Latest Developments
13.5 Merck & Co., Inc.
13.5.1 Merck & Co., Inc. Company Information
13.5.2 Merck & Co., Inc. Aurora Kinase A Product Portfolios and Specifications
13.5.3 Merck & Co., Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Merck & Co., Inc. Main Business Overview
13.5.5 Merck & Co., Inc. Latest Developments
13.6 Millennium Pharmaceuticals, Inc.
13.6.1 Millennium Pharmaceuticals, Inc. Company Information
13.6.2 Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolios and Specifications
13.6.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Millennium Pharmaceuticals, Inc. Main Business Overview
13.6.5 Millennium Pharmaceuticals, Inc. Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Aurora Kinase A Product Portfolios and Specifications
13.7.3 Sanofi Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Sareum Holdings Plc
13.8.1 Sareum Holdings Plc Company Information
13.8.2 Sareum Holdings Plc Aurora Kinase A Product Portfolios and Specifications
13.8.3 Sareum Holdings Plc Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sareum Holdings Plc Main Business Overview
13.8.5 Sareum Holdings Plc Latest Developments
13.9 Sigma-Tau S.p.A.
13.9.1 Sigma-Tau S.p.A. Company Information
13.9.2 Sigma-Tau S.p.A. Aurora Kinase A Product Portfolios and Specifications
13.9.3 Sigma-Tau S.p.A. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Sigma-Tau S.p.A. Main Business Overview
13.9.5 Sigma-Tau S.p.A. Latest Developments
13.10 Taiho Pharmaceutical Co., Ltd.
13.10.1 Taiho Pharmaceutical Co., Ltd. Company Information
13.10.2 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolios and Specifications
13.10.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Taiho Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Taiho Pharmaceutical Co., Ltd. Latest Developments
13.11 Vertex Pharmaceuticals Incorporated
13.11.1 Vertex Pharmaceuticals Incorporated Company Information
13.11.2 Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolios and Specifications
13.11.3 Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Vertex Pharmaceuticals Incorporated Main Business Overview
13.11.5 Vertex Pharmaceuticals Incorporated Latest Developments
13.12 Vichem Chemie Research Ltd.
13.12.1 Vichem Chemie Research Ltd. Company Information
13.12.2 Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolios and Specifications
13.12.3 Vichem Chemie Research Ltd. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Vichem Chemie Research Ltd. Main Business Overview
13.12.5 Vichem Chemie Research Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Aurora Kinase A Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Aurora Kinase A by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Aurora Kinase A by Country/Region, 2020, 2024 & 2031
2.2 Aurora Kinase A Segment by Type
2.2.1 AMG-900
2.2.2 Danusertib
2.2.3 ENMD-2076
2.2.4 Ilorasertib
2.2.5 Others
2.3 Aurora Kinase A Sales by Type
2.3.1 Global Aurora Kinase A Sales Market Share by Type (2020-2025)
2.3.2 Global Aurora Kinase A Revenue and Market Share by Type (2020-2025)
2.3.3 Global Aurora Kinase A Sale Price by Type (2020-2025)
2.4 Aurora Kinase A Segment by Application
2.4.1 Ovarian Cancer
2.4.2 Anaplastic Large Cell Lymphoma
2.4.3 Brain Tumor
2.4.4 Others
2.5 Aurora Kinase A Sales by Application
2.5.1 Global Aurora Kinase A Sale Market Share by Application (2020-2025)
2.5.2 Global Aurora Kinase A Revenue and Market Share by Application (2020-2025)
2.5.3 Global Aurora Kinase A Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Aurora Kinase A Breakdown Data by Company
3.1.1 Global Aurora Kinase A Annual Sales by Company (2020-2025)
3.1.2 Global Aurora Kinase A Sales Market Share by Company (2020-2025)
3.2 Global Aurora Kinase A Annual Revenue by Company (2020-2025)
3.2.1 Global Aurora Kinase A Revenue by Company (2020-2025)
3.2.2 Global Aurora Kinase A Revenue Market Share by Company (2020-2025)
3.3 Global Aurora Kinase A Sale Price by Company
3.4 Key Manufacturers Aurora Kinase A Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aurora Kinase A Product Location Distribution
3.4.2 Players Aurora Kinase A Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AURORA KINASE A BY GEOGRAPHIC REGION
4.1 World Historic Aurora Kinase A Market Size by Geographic Region (2020-2025)
4.1.1 Global Aurora Kinase A Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Aurora Kinase A Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Aurora Kinase A Market Size by Country/Region (2020-2025)
4.2.1 Global Aurora Kinase A Annual Sales by Country/Region (2020-2025)
4.2.2 Global Aurora Kinase A Annual Revenue by Country/Region (2020-2025)
4.3 Americas Aurora Kinase A Sales Growth
4.4 APAC Aurora Kinase A Sales Growth
4.5 Europe Aurora Kinase A Sales Growth
4.6 Middle East & Africa Aurora Kinase A Sales Growth
5 AMERICAS
5.1 Americas Aurora Kinase A Sales by Country
5.1.1 Americas Aurora Kinase A Sales by Country (2020-2025)
5.1.2 Americas Aurora Kinase A Revenue by Country (2020-2025)
5.2 Americas Aurora Kinase A Sales by Type (2020-2025)
5.3 Americas Aurora Kinase A Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aurora Kinase A Sales by Region
6.1.1 APAC Aurora Kinase A Sales by Region (2020-2025)
6.1.2 APAC Aurora Kinase A Revenue by Region (2020-2025)
6.2 APAC Aurora Kinase A Sales by Type (2020-2025)
6.3 APAC Aurora Kinase A Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Aurora Kinase A by Country
7.1.1 Europe Aurora Kinase A Sales by Country (2020-2025)
7.1.2 Europe Aurora Kinase A Revenue by Country (2020-2025)
7.2 Europe Aurora Kinase A Sales by Type (2020-2025)
7.3 Europe Aurora Kinase A Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Aurora Kinase A by Country
8.1.1 Middle East & Africa Aurora Kinase A Sales by Country (2020-2025)
8.1.2 Middle East & Africa Aurora Kinase A Revenue by Country (2020-2025)
8.2 Middle East & Africa Aurora Kinase A Sales by Type (2020-2025)
8.3 Middle East & Africa Aurora Kinase A Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aurora Kinase A
10.3 Manufacturing Process Analysis of Aurora Kinase A
10.4 Industry Chain Structure of Aurora Kinase A
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aurora Kinase A Distributors
11.3 Aurora Kinase A Customer
12 WORLD FORECAST REVIEW FOR AURORA KINASE A BY GEOGRAPHIC REGION
12.1 Global Aurora Kinase A Market Size Forecast by Region
12.1.1 Global Aurora Kinase A Forecast by Region (2026-2031)
12.1.2 Global Aurora Kinase A Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Aurora Kinase A Forecast by Type (2026-2031)
12.7 Global Aurora Kinase A Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AbbVie Inc.
13.1.1 AbbVie Inc. Company Information
13.1.2 AbbVie Inc. Aurora Kinase A Product Portfolios and Specifications
13.1.3 AbbVie Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AbbVie Inc. Main Business Overview
13.1.5 AbbVie Inc. Latest Developments
13.2 Amgen Inc.
13.2.1 Amgen Inc. Company Information
13.2.2 Amgen Inc. Aurora Kinase A Product Portfolios and Specifications
13.2.3 Amgen Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Amgen Inc. Main Business Overview
13.2.5 Amgen Inc. Latest Developments
13.3 Astex Pharmaceuticals, Inc.
13.3.1 Astex Pharmaceuticals, Inc. Company Information
13.3.2 Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolios and Specifications
13.3.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Astex Pharmaceuticals, Inc. Main Business Overview
13.3.5 Astex Pharmaceuticals, Inc. Latest Developments
13.4 CASI Pharmaceuticals Inc.
13.4.1 CASI Pharmaceuticals Inc. Company Information
13.4.2 CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolios and Specifications
13.4.3 CASI Pharmaceuticals Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 CASI Pharmaceuticals Inc. Main Business Overview
13.4.5 CASI Pharmaceuticals Inc. Latest Developments
13.5 Merck & Co., Inc.
13.5.1 Merck & Co., Inc. Company Information
13.5.2 Merck & Co., Inc. Aurora Kinase A Product Portfolios and Specifications
13.5.3 Merck & Co., Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Merck & Co., Inc. Main Business Overview
13.5.5 Merck & Co., Inc. Latest Developments
13.6 Millennium Pharmaceuticals, Inc.
13.6.1 Millennium Pharmaceuticals, Inc. Company Information
13.6.2 Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolios and Specifications
13.6.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Millennium Pharmaceuticals, Inc. Main Business Overview
13.6.5 Millennium Pharmaceuticals, Inc. Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Aurora Kinase A Product Portfolios and Specifications
13.7.3 Sanofi Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Sareum Holdings Plc
13.8.1 Sareum Holdings Plc Company Information
13.8.2 Sareum Holdings Plc Aurora Kinase A Product Portfolios and Specifications
13.8.3 Sareum Holdings Plc Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sareum Holdings Plc Main Business Overview
13.8.5 Sareum Holdings Plc Latest Developments
13.9 Sigma-Tau S.p.A.
13.9.1 Sigma-Tau S.p.A. Company Information
13.9.2 Sigma-Tau S.p.A. Aurora Kinase A Product Portfolios and Specifications
13.9.3 Sigma-Tau S.p.A. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Sigma-Tau S.p.A. Main Business Overview
13.9.5 Sigma-Tau S.p.A. Latest Developments
13.10 Taiho Pharmaceutical Co., Ltd.
13.10.1 Taiho Pharmaceutical Co., Ltd. Company Information
13.10.2 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolios and Specifications
13.10.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Taiho Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Taiho Pharmaceutical Co., Ltd. Latest Developments
13.11 Vertex Pharmaceuticals Incorporated
13.11.1 Vertex Pharmaceuticals Incorporated Company Information
13.11.2 Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolios and Specifications
13.11.3 Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Vertex Pharmaceuticals Incorporated Main Business Overview
13.11.5 Vertex Pharmaceuticals Incorporated Latest Developments
13.12 Vichem Chemie Research Ltd.
13.12.1 Vichem Chemie Research Ltd. Company Information
13.12.2 Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolios and Specifications
13.12.3 Vichem Chemie Research Ltd. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Vichem Chemie Research Ltd. Main Business Overview
13.12.5 Vichem Chemie Research Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Aurora Kinase A Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Aurora Kinase A Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of AMG-900
Table 4. Major Players of Danusertib
Table 5. Major Players of ENMD-2076
Table 6. Major Players of Ilorasertib
Table 7. Major Players of Others
Table 8. Global Aurora Kinase A Sales by Type (2020-2025) & (K Pcs)
Table 9. Global Aurora Kinase A Sales Market Share by Type (2020-2025)
Table 10. Global Aurora Kinase A Revenue by Type (2020-2025) & ($ million)
Table 11. Global Aurora Kinase A Revenue Market Share by Type (2020-2025)
Table 12. Global Aurora Kinase A Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global Aurora Kinase A Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Aurora Kinase A Sale Market Share by Application (2020-2025)
Table 15. Global Aurora Kinase A Revenue by Application (2020-2025) & ($ million)
Table 16. Global Aurora Kinase A Revenue Market Share by Application (2020-2025)
Table 17. Global Aurora Kinase A Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Aurora Kinase A Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Aurora Kinase A Sales Market Share by Company (2020-2025)
Table 20. Global Aurora Kinase A Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Aurora Kinase A Revenue Market Share by Company (2020-2025)
Table 22. Global Aurora Kinase A Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Aurora Kinase A Producing Area Distribution and Sales Area
Table 24. Players Aurora Kinase A Products Offered
Table 25. Aurora Kinase A Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Aurora Kinase A Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Aurora Kinase A Sales Market Share Geographic Region (2020-2025)
Table 30. Global Aurora Kinase A Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Aurora Kinase A Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Aurora Kinase A Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Aurora Kinase A Sales Market Share by Country/Region (2020-2025)
Table 34. Global Aurora Kinase A Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Aurora Kinase A Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Aurora Kinase A Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Aurora Kinase A Sales Market Share by Country (2020-2025)
Table 38. Americas Aurora Kinase A Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Aurora Kinase A Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas Aurora Kinase A Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Aurora Kinase A Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Aurora Kinase A Sales Market Share by Region (2020-2025)
Table 43. APAC Aurora Kinase A Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Aurora Kinase A Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC Aurora Kinase A Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Aurora Kinase A Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Aurora Kinase A Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Aurora Kinase A Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe Aurora Kinase A Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Aurora Kinase A Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Aurora Kinase A Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Aurora Kinase A Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Aurora Kinase A Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Aurora Kinase A
Table 55. Key Market Challenges & Risks of Aurora Kinase A
Table 56. Key Industry Trends of Aurora Kinase A
Table 57. Aurora Kinase A Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Aurora Kinase A Distributors List
Table 60. Aurora Kinase A Customer List
Table 61. Global Aurora Kinase A Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global Aurora Kinase A Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Aurora Kinase A Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Aurora Kinase A Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Aurora Kinase A Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Aurora Kinase A Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Aurora Kinase A Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Aurora Kinase A Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Aurora Kinase A Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Aurora Kinase A Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Aurora Kinase A Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global Aurora Kinase A Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Aurora Kinase A Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global Aurora Kinase A Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. AbbVie Inc. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 76. AbbVie Inc. Aurora Kinase A Product Portfolios and Specifications
Table 77. AbbVie Inc. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. AbbVie Inc. Main Business
Table 79. AbbVie Inc. Latest Developments
Table 80. Amgen Inc. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 81. Amgen Inc. Aurora Kinase A Product Portfolios and Specifications
Table 82. Amgen Inc. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Amgen Inc. Main Business
Table 84. Amgen Inc. Latest Developments
Table 85. Astex Pharmaceuticals, Inc. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 86. Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolios and Specifications
Table 87. Astex Pharmaceuticals, Inc. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Astex Pharmaceuticals, Inc. Main Business
Table 89. Astex Pharmaceuticals, Inc. Latest Developments
Table 90. CASI Pharmaceuticals Inc. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 91. CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolios and Specifications
Table 92. CASI Pharmaceuticals Inc. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. CASI Pharmaceuticals Inc. Main Business
Table 94. CASI Pharmaceuticals Inc. Latest Developments
Table 95. Merck & Co., Inc. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 96. Merck & Co., Inc. Aurora Kinase A Product Portfolios and Specifications
Table 97. Merck & Co., Inc. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Merck & Co., Inc. Main Business
Table 99. Merck & Co., Inc. Latest Developments
Table 100. Millennium Pharmaceuticals, Inc. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 101. Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolios and Specifications
Table 102. Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Millennium Pharmaceuticals, Inc. Main Business
Table 104. Millennium Pharmaceuticals, Inc. Latest Developments
Table 105. Sanofi Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 106. Sanofi Aurora Kinase A Product Portfolios and Specifications
Table 107. Sanofi Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Sanofi Main Business
Table 109. Sanofi Latest Developments
Table 110. Sareum Holdings Plc Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 111. Sareum Holdings Plc Aurora Kinase A Product Portfolios and Specifications
Table 112. Sareum Holdings Plc Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Sareum Holdings Plc Main Business
Table 114. Sareum Holdings Plc Latest Developments
Table 115. Sigma-Tau S.p.A. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 116. Sigma-Tau S.p.A. Aurora Kinase A Product Portfolios and Specifications
Table 117. Sigma-Tau S.p.A. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Sigma-Tau S.p.A. Main Business
Table 119. Sigma-Tau S.p.A. Latest Developments
Table 120. Taiho Pharmaceutical Co., Ltd. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 121. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolios and Specifications
Table 122. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Taiho Pharmaceutical Co., Ltd. Main Business
Table 124. Taiho Pharmaceutical Co., Ltd. Latest Developments
Table 125. Vertex Pharmaceuticals Incorporated Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 126. Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolios and Specifications
Table 127. Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Vertex Pharmaceuticals Incorporated Main Business
Table 129. Vertex Pharmaceuticals Incorporated Latest Developments
Table 130. Vichem Chemie Research Ltd. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 131. Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolios and Specifications
Table 132. Vichem Chemie Research Ltd. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Vichem Chemie Research Ltd. Main Business
Table 134. Vichem Chemie Research Ltd. Latest Developments
Table 1. Aurora Kinase A Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Aurora Kinase A Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of AMG-900
Table 4. Major Players of Danusertib
Table 5. Major Players of ENMD-2076
Table 6. Major Players of Ilorasertib
Table 7. Major Players of Others
Table 8. Global Aurora Kinase A Sales by Type (2020-2025) & (K Pcs)
Table 9. Global Aurora Kinase A Sales Market Share by Type (2020-2025)
Table 10. Global Aurora Kinase A Revenue by Type (2020-2025) & ($ million)
Table 11. Global Aurora Kinase A Revenue Market Share by Type (2020-2025)
Table 12. Global Aurora Kinase A Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global Aurora Kinase A Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Aurora Kinase A Sale Market Share by Application (2020-2025)
Table 15. Global Aurora Kinase A Revenue by Application (2020-2025) & ($ million)
Table 16. Global Aurora Kinase A Revenue Market Share by Application (2020-2025)
Table 17. Global Aurora Kinase A Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Aurora Kinase A Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Aurora Kinase A Sales Market Share by Company (2020-2025)
Table 20. Global Aurora Kinase A Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Aurora Kinase A Revenue Market Share by Company (2020-2025)
Table 22. Global Aurora Kinase A Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Aurora Kinase A Producing Area Distribution and Sales Area
Table 24. Players Aurora Kinase A Products Offered
Table 25. Aurora Kinase A Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Aurora Kinase A Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Aurora Kinase A Sales Market Share Geographic Region (2020-2025)
Table 30. Global Aurora Kinase A Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Aurora Kinase A Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Aurora Kinase A Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Aurora Kinase A Sales Market Share by Country/Region (2020-2025)
Table 34. Global Aurora Kinase A Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Aurora Kinase A Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Aurora Kinase A Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Aurora Kinase A Sales Market Share by Country (2020-2025)
Table 38. Americas Aurora Kinase A Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Aurora Kinase A Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas Aurora Kinase A Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Aurora Kinase A Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Aurora Kinase A Sales Market Share by Region (2020-2025)
Table 43. APAC Aurora Kinase A Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Aurora Kinase A Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC Aurora Kinase A Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Aurora Kinase A Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Aurora Kinase A Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Aurora Kinase A Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe Aurora Kinase A Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Aurora Kinase A Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Aurora Kinase A Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Aurora Kinase A Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Aurora Kinase A Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Aurora Kinase A
Table 55. Key Market Challenges & Risks of Aurora Kinase A
Table 56. Key Industry Trends of Aurora Kinase A
Table 57. Aurora Kinase A Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Aurora Kinase A Distributors List
Table 60. Aurora Kinase A Customer List
Table 61. Global Aurora Kinase A Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global Aurora Kinase A Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Aurora Kinase A Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Aurora Kinase A Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Aurora Kinase A Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Aurora Kinase A Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Aurora Kinase A Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Aurora Kinase A Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Aurora Kinase A Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Aurora Kinase A Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Aurora Kinase A Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global Aurora Kinase A Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Aurora Kinase A Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global Aurora Kinase A Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. AbbVie Inc. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 76. AbbVie Inc. Aurora Kinase A Product Portfolios and Specifications
Table 77. AbbVie Inc. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. AbbVie Inc. Main Business
Table 79. AbbVie Inc. Latest Developments
Table 80. Amgen Inc. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 81. Amgen Inc. Aurora Kinase A Product Portfolios and Specifications
Table 82. Amgen Inc. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Amgen Inc. Main Business
Table 84. Amgen Inc. Latest Developments
Table 85. Astex Pharmaceuticals, Inc. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 86. Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolios and Specifications
Table 87. Astex Pharmaceuticals, Inc. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Astex Pharmaceuticals, Inc. Main Business
Table 89. Astex Pharmaceuticals, Inc. Latest Developments
Table 90. CASI Pharmaceuticals Inc. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 91. CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolios and Specifications
Table 92. CASI Pharmaceuticals Inc. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. CASI Pharmaceuticals Inc. Main Business
Table 94. CASI Pharmaceuticals Inc. Latest Developments
Table 95. Merck & Co., Inc. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 96. Merck & Co., Inc. Aurora Kinase A Product Portfolios and Specifications
Table 97. Merck & Co., Inc. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Merck & Co., Inc. Main Business
Table 99. Merck & Co., Inc. Latest Developments
Table 100. Millennium Pharmaceuticals, Inc. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 101. Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolios and Specifications
Table 102. Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Millennium Pharmaceuticals, Inc. Main Business
Table 104. Millennium Pharmaceuticals, Inc. Latest Developments
Table 105. Sanofi Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 106. Sanofi Aurora Kinase A Product Portfolios and Specifications
Table 107. Sanofi Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Sanofi Main Business
Table 109. Sanofi Latest Developments
Table 110. Sareum Holdings Plc Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 111. Sareum Holdings Plc Aurora Kinase A Product Portfolios and Specifications
Table 112. Sareum Holdings Plc Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Sareum Holdings Plc Main Business
Table 114. Sareum Holdings Plc Latest Developments
Table 115. Sigma-Tau S.p.A. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 116. Sigma-Tau S.p.A. Aurora Kinase A Product Portfolios and Specifications
Table 117. Sigma-Tau S.p.A. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Sigma-Tau S.p.A. Main Business
Table 119. Sigma-Tau S.p.A. Latest Developments
Table 120. Taiho Pharmaceutical Co., Ltd. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 121. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolios and Specifications
Table 122. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Taiho Pharmaceutical Co., Ltd. Main Business
Table 124. Taiho Pharmaceutical Co., Ltd. Latest Developments
Table 125. Vertex Pharmaceuticals Incorporated Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 126. Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolios and Specifications
Table 127. Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Vertex Pharmaceuticals Incorporated Main Business
Table 129. Vertex Pharmaceuticals Incorporated Latest Developments
Table 130. Vichem Chemie Research Ltd. Basic Information, Aurora Kinase A Manufacturing Base, Sales Area and Its Competitors
Table 131. Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolios and Specifications
Table 132. Vichem Chemie Research Ltd. Aurora Kinase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Vichem Chemie Research Ltd. Main Business
Table 134. Vichem Chemie Research Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Aurora Kinase A
Figure 2. Aurora Kinase A Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aurora Kinase A Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Aurora Kinase A Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Aurora Kinase A Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Aurora Kinase A Sales Market Share by Country/Region (2024)
Figure 10. Aurora Kinase A Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of AMG-900
Figure 12. Product Picture of Danusertib
Figure 13. Product Picture of ENMD-2076
Figure 14. Product Picture of Ilorasertib
Figure 15. Product Picture of Others
Figure 16. Global Aurora Kinase A Sales Market Share by Type in 2025
Figure 17. Global Aurora Kinase A Revenue Market Share by Type (2020-2025)
Figure 18. Aurora Kinase A Consumed in Ovarian Cancer
Figure 19. Global Aurora Kinase A Market: Ovarian Cancer (2020-2025) & (K Pcs)
Figure 20. Aurora Kinase A Consumed in Anaplastic Large Cell Lymphoma
Figure 21. Global Aurora Kinase A Market: Anaplastic Large Cell Lymphoma (2020-2025) & (K Pcs)
Figure 22. Aurora Kinase A Consumed in Brain Tumor
Figure 23. Global Aurora Kinase A Market: Brain Tumor (2020-2025) & (K Pcs)
Figure 24. Aurora Kinase A Consumed in Others
Figure 25. Global Aurora Kinase A Market: Others (2020-2025) & (K Pcs)
Figure 26. Global Aurora Kinase A Sale Market Share by Application (2024)
Figure 27. Global Aurora Kinase A Revenue Market Share by Application in 2025
Figure 28. Aurora Kinase A Sales by Company in 2025 (K Pcs)
Figure 29. Global Aurora Kinase A Sales Market Share by Company in 2025
Figure 30. Aurora Kinase A Revenue by Company in 2025 ($ millions)
Figure 31. Global Aurora Kinase A Revenue Market Share by Company in 2025
Figure 32. Global Aurora Kinase A Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Aurora Kinase A Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Aurora Kinase A Sales 2020-2025 (K Pcs)
Figure 35. Americas Aurora Kinase A Revenue 2020-2025 ($ millions)
Figure 36. APAC Aurora Kinase A Sales 2020-2025 (K Pcs)
Figure 37. APAC Aurora Kinase A Revenue 2020-2025 ($ millions)
Figure 38. Europe Aurora Kinase A Sales 2020-2025 (K Pcs)
Figure 39. Europe Aurora Kinase A Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Aurora Kinase A Sales 2020-2025 (K Pcs)
Figure 41. Middle East & Africa Aurora Kinase A Revenue 2020-2025 ($ millions)
Figure 42. Americas Aurora Kinase A Sales Market Share by Country in 2025
Figure 43. Americas Aurora Kinase A Revenue Market Share by Country (2020-2025)
Figure 44. Americas Aurora Kinase A Sales Market Share by Type (2020-2025)
Figure 45. Americas Aurora Kinase A Sales Market Share by Application (2020-2025)
Figure 46. United States Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Aurora Kinase A Sales Market Share by Region in 2025
Figure 51. APAC Aurora Kinase A Revenue Market Share by Region (2020-2025)
Figure 52. APAC Aurora Kinase A Sales Market Share by Type (2020-2025)
Figure 53. APAC Aurora Kinase A Sales Market Share by Application (2020-2025)
Figure 54. China Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 58. India Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Aurora Kinase A Sales Market Share by Country in 2025
Figure 62. Europe Aurora Kinase A Revenue Market Share by Country (2020-2025)
Figure 63. Europe Aurora Kinase A Sales Market Share by Type (2020-2025)
Figure 64. Europe Aurora Kinase A Sales Market Share by Application (2020-2025)
Figure 65. Germany Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 66. France Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Aurora Kinase A Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Aurora Kinase A Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Aurora Kinase A Sales Market Share by Application (2020-2025)
Figure 73. Egypt Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Aurora Kinase A in 2025
Figure 79. Manufacturing Process Analysis of Aurora Kinase A
Figure 80. Industry Chain Structure of Aurora Kinase A
Figure 81. Channels of Distribution
Figure 82. Global Aurora Kinase A Sales Market Forecast by Region (2026-2031)
Figure 83. Global Aurora Kinase A Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Aurora Kinase A Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Aurora Kinase A Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Aurora Kinase A Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Aurora Kinase A Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Aurora Kinase A
Figure 2. Aurora Kinase A Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aurora Kinase A Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Aurora Kinase A Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Aurora Kinase A Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Aurora Kinase A Sales Market Share by Country/Region (2024)
Figure 10. Aurora Kinase A Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of AMG-900
Figure 12. Product Picture of Danusertib
Figure 13. Product Picture of ENMD-2076
Figure 14. Product Picture of Ilorasertib
Figure 15. Product Picture of Others
Figure 16. Global Aurora Kinase A Sales Market Share by Type in 2025
Figure 17. Global Aurora Kinase A Revenue Market Share by Type (2020-2025)
Figure 18. Aurora Kinase A Consumed in Ovarian Cancer
Figure 19. Global Aurora Kinase A Market: Ovarian Cancer (2020-2025) & (K Pcs)
Figure 20. Aurora Kinase A Consumed in Anaplastic Large Cell Lymphoma
Figure 21. Global Aurora Kinase A Market: Anaplastic Large Cell Lymphoma (2020-2025) & (K Pcs)
Figure 22. Aurora Kinase A Consumed in Brain Tumor
Figure 23. Global Aurora Kinase A Market: Brain Tumor (2020-2025) & (K Pcs)
Figure 24. Aurora Kinase A Consumed in Others
Figure 25. Global Aurora Kinase A Market: Others (2020-2025) & (K Pcs)
Figure 26. Global Aurora Kinase A Sale Market Share by Application (2024)
Figure 27. Global Aurora Kinase A Revenue Market Share by Application in 2025
Figure 28. Aurora Kinase A Sales by Company in 2025 (K Pcs)
Figure 29. Global Aurora Kinase A Sales Market Share by Company in 2025
Figure 30. Aurora Kinase A Revenue by Company in 2025 ($ millions)
Figure 31. Global Aurora Kinase A Revenue Market Share by Company in 2025
Figure 32. Global Aurora Kinase A Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Aurora Kinase A Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Aurora Kinase A Sales 2020-2025 (K Pcs)
Figure 35. Americas Aurora Kinase A Revenue 2020-2025 ($ millions)
Figure 36. APAC Aurora Kinase A Sales 2020-2025 (K Pcs)
Figure 37. APAC Aurora Kinase A Revenue 2020-2025 ($ millions)
Figure 38. Europe Aurora Kinase A Sales 2020-2025 (K Pcs)
Figure 39. Europe Aurora Kinase A Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Aurora Kinase A Sales 2020-2025 (K Pcs)
Figure 41. Middle East & Africa Aurora Kinase A Revenue 2020-2025 ($ millions)
Figure 42. Americas Aurora Kinase A Sales Market Share by Country in 2025
Figure 43. Americas Aurora Kinase A Revenue Market Share by Country (2020-2025)
Figure 44. Americas Aurora Kinase A Sales Market Share by Type (2020-2025)
Figure 45. Americas Aurora Kinase A Sales Market Share by Application (2020-2025)
Figure 46. United States Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Aurora Kinase A Sales Market Share by Region in 2025
Figure 51. APAC Aurora Kinase A Revenue Market Share by Region (2020-2025)
Figure 52. APAC Aurora Kinase A Sales Market Share by Type (2020-2025)
Figure 53. APAC Aurora Kinase A Sales Market Share by Application (2020-2025)
Figure 54. China Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 58. India Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Aurora Kinase A Sales Market Share by Country in 2025
Figure 62. Europe Aurora Kinase A Revenue Market Share by Country (2020-2025)
Figure 63. Europe Aurora Kinase A Sales Market Share by Type (2020-2025)
Figure 64. Europe Aurora Kinase A Sales Market Share by Application (2020-2025)
Figure 65. Germany Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 66. France Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Aurora Kinase A Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Aurora Kinase A Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Aurora Kinase A Sales Market Share by Application (2020-2025)
Figure 73. Egypt Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Aurora Kinase A Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Aurora Kinase A in 2025
Figure 79. Manufacturing Process Analysis of Aurora Kinase A
Figure 80. Industry Chain Structure of Aurora Kinase A
Figure 81. Channels of Distribution
Figure 82. Global Aurora Kinase A Sales Market Forecast by Region (2026-2031)
Figure 83. Global Aurora Kinase A Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Aurora Kinase A Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Aurora Kinase A Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Aurora Kinase A Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Aurora Kinase A Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Interleukin-11 (IL-11) Market Growth 2023-2029
US$ 3,660.00
March 2023
104 pages
Global Walk In Cold & Freezer Rooms Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
November 2024
94 pages
Global Dental X-Ray Units Market Growth 2024-2030
US$ 3,660.00
December 2024
157 pages
